Leading contract diagnostics organization has completed construction of a 12,000 square foot addition to their office in Irvine, CA creating a 30,000 square foot headquarters in Irvine, CA. Irvine, CA—February 1, 2017—ResearchDx, Inc. announced today that construction is completed on a major addition to their Orange County headquarters. The company’s building at 5 Mason in…Read more
Recent Posts by pdx_admin
Say the words “HER2 gene amplification” and what immediately comes to mind is breast cancer. But did you know other cancers, including those of the stomach and esophagus (collectively called gastroesophagel adenocarinoma or GEA) can have too many (> 6) copies of the HER2 gene? That’s right, an estimated 20% of GEA cancers harbor an…Read more
Leading contract diagnostics organization demonstrates the value of DNA-based testing for identifying the HER2-Low genomic subtype in high-risk HER2 equivocal breast cancer Irvine, CA—December 1, 2016—ResearchDx/PacificDx announced today that it will share findings demonstrating the value of DNA microarray comparative genomic hybridization (array CGH) for HER2 genomic subtyping in breast cancer patients at this year’s…Read more
Testing Provides Definitive Results for HER2 Equivocal Breast Cancer Irvine, California and San Antonio, Texas, August 22, 2016 — Determining the HER2 (ERBB2) gene status in breast tumor tissue is critical for identifying patients predicted to respond to targeted anti-HER2 therapy. Yet, in an estimated 10-20% of the over 200,000 new breast cancers diagnosed each…Read more
Recent Comments by pdx_admin
No comments by pdx_admin yet.